Publications

  1. Langford CA, Monach PA, Specks U, Seo P, Cuthbertson D, McAlear CA, Ytterberg SR, Hoffman GS, Krischer JP, Merkel PA, Vasculitis Clinical Research Consortium. An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's). Ann Rheum Dis. 2014 Jul; 73(7):1376-9. Epub 2013 Dec 09.
    View PubMed
  2. Bongartz T, Glazebrook KN, Kavros SJ, Murthy NS, Merry SP, Franz WB 3rd, Michet CJ, Akkara Veetil BM, Davis JM 3rd, Mason TG 2nd, Warrington KJ, Ytterberg SR, Matteson EL, Crowson CS, Leng S, McCollough CH. Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study. Ann Rheum Dis. 2014 Mar 25. [Epub ahead of print]
    View PubMed
  3. Vaszar LT, Orzechowski NM, Specks U, Ytterberg SR, Loftus EV Jr, Mark EJ, Tazelaar HD. Coexistent pulmonary granulomatosis with polyangiitis (Wegener granulomatosis) and Crohn disease. Am J Surg Pathol. 2014 Mar; 38(3):354-9.
    View PubMed
  4. Cartin-Ceba R, Peikert T, Ashrani A, Keogh K, Wylam ME, Ytterberg S, Specks U. Primary antiphospholipid syndrome-associated diffuse alveolar hemorrhage. Arthritis Care Res (Hoboken). 2014 Feb; 66(2):301-10.
    View PubMed
  5. Kermani TA, Warrington KJ, Crowson CS, Ytterberg SR, Hunder GG, Gabriel SE, Matteson EL. Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis. 2013 Dec; 72(12):1989-94. Epub 2012 Dec 19.
    View PubMed
  6. Grayson PC, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Maksimowicz-McKinnon K, Monach PA, Seo P, Specks U, Ytterberg SR, Merkel PA, Vasculitis Clinical Research Consortium. New features of disease after diagnosis in 6 forms of systemic vasculitis. J Rheumatol. 2013 Nov; 40(11):1905-12. Epub 2013 Aug 01.
    View PubMed
  7. Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Viviano L, Ding L, Sejismundo LP, Mieras K, Ikle D, Jepson B, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2013 Sep; 65(9):2441-9.
    View PubMed
  8. Xie G, Roshandel D, Sherva R, Monach PA, Lu EY, Kung T, Carrington K, Zhang SS, Pulit SL, Ripke S, Carette S, Dellaripa PF, Edberg JC, Hoffman GS, Khalidi N, Langford CA, Mahr AD, St Clair EW, Seo P, Specks U, Spiera RF, Stone JH, Ytterberg SR, Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis. Arthritis Rheum. 2013 Sep; 65(9):2457-68.
    View PubMed
  9. Saruhan-Direskeneli G, Hughes T, Aksu K, Keser G, Coit P, Aydin SZ, Alibaz-Oner F, Kamali S, Inanc M, Carette S, Hoffman GS, Akar S, Onen F, Akkoc N, Khalidi NA, Koening C, Karadag O, Kiraz S, Langford CA, McAlear CA, Ozbalkan Z, Ates A, Karaaslan Y, Identification of multiple genetic susceptibility loci in Takayasu arteritis. Am J Hum Genet. 2013 Aug 8; 93(2):298-305. Epub 2013 Jul 03.
    View PubMed
  10. Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med. 2013 Aug 1; 369(5):417-27.
    View PubMed
  11. Monach PA, Warner RL, Tomasson G, Specks U, Stone JH, Ding L, Fervenza FC, Fessler BJ, Hoffman GS, Ikle D, Kallenberg CG, Krischer J, Langford CA, Mueller M, Seo P, St Clair EW, Spiera R, Tchao N, Ytterberg SR, Johnson KJ, Merkel PA. Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis. Ann Rheum Dis. 2013 Aug; 72(8):1342-50. Epub 2012 Sep 12.
    View PubMed
  12. Lieberthal JG, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Maksimowicz-McKinnon K, Seo P, Specks U, Ytterberg SR, Merkel PA, Monach PA, Vasculitis Clinical Research Consortium. urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis. J Rheumatol. 2013 May; 40(5):674-83. Epub 2013 Apr 01.
    View PubMed
  13. Lopez De Padilla CM, McNallan KT, Crowson CS, Bilgic H, Bram RJ, Hein MS, Ytterberg SR, Amin S, Peterson EJ, Baechler EC, Reed AM. BAFF expression correlates with idiopathic inflammatory myopathy disease activity measures and autoantibodies. J Rheumatol. 2013 Mar; 40(3):294-302. Epub 2013 Jan 15.
    View PubMed
  14. Miller FW, Cooper RG, Vencovsky J, Rider LG, Danko K, Wedderburn LR, Lundberg IE, Pachman LM, Reed AM, Ytterberg SR, Padyukov L, Selva-O'Callaghan A, Radstake TRDJ, Isenberg DA, Chinoy H, Ollier WER, O'Hanlon TP, Peng B, Lee A, Lamb JA, Chen W, Amos CI, G Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. Arthritis Rheum. 2013; 65(12):3239-47.
  15. Reed AM, Peterson E, Bilgic H, Ytterberg SR, Amin S, Hein MS, Crowson CS, Ernste F, Gillespie EB. Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course. Arthritis Rheum. 2012 Dec; 64(12):4078-86.
    View PubMed
  16. Cartin-Ceba R, Golbin JM, Keogh KA, Peikert T, Sanchez-Menendez M, Ytterberg SR, Fervenza FC, Specks U. Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center. Arthritis Rheum. 2012 Nov; 64(11):3770-8.
    View PubMed
  17. Alexanderson H, Reed AM, Ytterberg SR. The Myositis Activities Profile -- initial validation for assessment of polymyositis/dermatomyositis in the USA. J Rheumatol. 2012 Nov; 39(11):2134-41. Epub 2012 Sep 01.
    View PubMed
  18. Grayson PC, Maksimowicz-McKinnon K, Clark TM, Tomasson G, Cuthbertson D, Carette S, Khalidi NA, Langford CA, Monach PA, Seo P, Warrington KJ, Ytterberg SR, Hoffman GS, Merkel PA, Vasculitis Clinical Research Consortium. Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis. Ann Rheum Dis. 2012 Aug; 71(8):1329-34. Epub 2012 Feb 10.
    View PubMed
  19. Kermani TA, Schmidt J, Crowson CS, Ytterberg SR, Hunder GG, Matteson EL, Warrington KJ. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum. 2012 Jun; 41(6):866-71. Epub 2011 Nov 25.
    View PubMed
  20. Grayson PC, Tomasson G, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Langford CA, McAlear CA, Monach PA, Seo P, Warrington KJ, Ytterberg SR, Merkel PA, Vasculitis Clinical Research Consortium. Association of vascular physical examination findings and arteriographic lesions in large vessel vasculitis. J Rheumatol. 2012 Feb; 39(2):303-9. Epub 2011 Dec 15.
    View PubMed
  21. Tomasson G, Boers M, Walsh M, LaValley M, Cuthbertson D, Carette S, Davis JC, Hoffman GS, Khalidi NA, Langford CA, McAlear CA, McCune WJ, Monach PA, Seo P, Specks U, Spiera R, St Clair EW, Stone JH, Ytterberg SR, Merkel PA. Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's). Arthritis Care Res (Hoboken). 2012 Feb; 64(2):273-9.
    View PubMed
  22. Monach PA, Kumpers P, Lukasz A, Tomasson G, Specks U, Stone JH, Cuthbertson D, Krischer J, Carette S, Ding L, Hoffman GS, Ikle D, Kallenberg CG, Khalidi NA, Langford CA, Seo P, St Clair EW, Spiera R, Tchao N, Ytterberg SR, Haubitz M, Merkel PA. Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis. PLoS One. 2012; 7(1):e30197. Epub 2012 Jan 18.
    View PubMed
  23. Kelley JM, Monach PA, Ji CY, Zhou YB, Wu JM, Tanaka S, Mahr AD, Johnson S, McAlear C, Cuthbertson D, Carette S, Davis JC, Dellaripa PF, Hoffman GS, Khalidi N, Langford CA, Seo P, St Clair EW, Specks U, Stone JH, Spiera RF, Ytterberg SR, Merkel PA, Edberg IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis. Proceedings Of The National Academy Of Sciences Of The United States Of. 2011 Dec 20; 108(51):20736-41.
  24. Monach PA, Tomasson G, Specks U, Stone JH, Cuthbertson D, Krischer J, Ding L, Fervenza FC, Fessler BJ, Hoffman GS, Ikle D, Kallenberg CG, Langford CA, Mueller M, Seo P, St Clair EW, Spiera R, Tchao N, Ytterberg SR, Gu YZ, Snyder RD, Merkel PA. Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2011 Dec; 63(12):3988-97.
    View PubMed
  25. Clowse ME, Copland SC, Hsieh TC, Chow SC, Hoffman GS, Merkel PA, Spiera RF, Davis JC Jr, McCune WJ, Ytterberg SR, St Clair EW, Allen NB, Specks U, Stone JH, WGET Research Group. Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's). Arthritis Care Res (Hoboken). 2011 Dec; 63(12):1777-81.
    View PubMed
  26. Silva F, Seo P, Schroeder DR, Stone JH, Merkel PA, Hoffman GS, Spiera R, Sebastian JK, Davis JC Jr, St Clair EW, Allen NB, McCune WJ, Ytterberg SR, Specks U, Wegener's Granulomatosis Etanercept Trial Research Group. Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohort. Arthritis Rheum. 2011 Aug; 63(8):2495-503.
    View PubMed
  27. Makol A, Ytterberg SR. Images in clinical medicine. Calcinosis cutis in systemic sclerosis. N Engl J Med. 2011 Jun 9; 364(23):2245.
    View PubMed
  28. Kermani TA, Ytterberg SR, Warrington KJ. Pneumocystis jiroveci pneumonia in giant cell arteritis: A case series. Arthritis Care Res (Hoboken). 2011 May; 63(5):761-5.
    View PubMed
  29. McCullough MB, Domire ZJ, Reed AM, Amin S, Ytterberg SR, Chen Q, An KN. Evaluation of muscles affected by myositis using magnetic resonance elastography. Muscle Nerve. 2011 Apr; 43(4):585-90. Epub 2011 Feb 11.
    View PubMed
  30. Schafer VS, Kermani TA, Crowson CS, Hunder GG, Gabriel SE, Ytterberg SR, Matteson EL, Warrington KJ. Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study. Rheumatology (Oxford). 2010 Nov; 49(11):2104-8. Epub 2010 Jul 13.
    View PubMed
  31. Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010 Jul 15; 363(3):221-32.
    View PubMed
  32. Kermani TA, Schafer VS, Crowson CS, Hunder GG, Ytterberg SR, Matteson EL, Gabriel SE, Warrington KJ. Cancer preceding giant cell arteritis: a case-control study. Arthritis Rheum. 2010 Jun; 62(6):1763-9.
    View PubMed
  33. Kermani TA, Schafer VS, Crowson CS, Hunder GG, Gabriel SE, Ytterberg SR, Matteson EL, Warrington KJ. Malignancy risk in patients with giant cell arteritis: a population-based cohort study. Arthritis Care Res (Hoboken). 2010 Feb; 62(2):149-54.
    View PubMed
  34. Bilgic H, Ytterberg SR, Amin S, McNallan KT, Wilson JC, Koeuth T, Ellingson S, Newman B, Bauer JW, Peterson EJ, Baechler EC, Reed AM. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis. Arthritis Rheum. 2009 Nov; 60(11):3436-46.
    View PubMed
  35. Ytterberg SR, Warrington KJ, Daniel Aletaha, Thomas Bush. Vasculitis working group: selected unanswered questions related to giant cell arteritis and anti-neutrophil cytoplasmic antibody-associated vasculitis. Joint Bone Spine. 2009 Jul; 76(4):440-3. Epub 2009 Jun 26.
    View PubMed
  36. Warrington KJ, Matteson EL, Ytterberg SR. Takayasu Arteritis. BMJ Point of Care Epocrates online. 2009 Mar 23.
  37. Finkielman JD, Merkel PA, Schroeder D, Hoffman GS, Spiera R, St Clair EW, Davis JC Jr, McCune WJ, Lears A, Ytterberg SR, Hummel AM, Viss MA, Peikert T, Stone JH, Specks U, WGET Research Group. Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis. Clin Exp Rheumatol. 2009 Jan-Feb; 27(1 Suppl 52):S45-52.
    View PubMed
  38. Wilson FC, Ytterberg SR, St Sauver JL, Reed AM. Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota. J Rheumatol. 2008 Mar; 35(3):445-7. Epub 2008 Jan 15.
    View PubMed
  39. Finkielman JD, Merkel PA, Schroeder D, Hoffman GS, Spiera R, St Clair EW, Davis JC Jr, McCune WJ, Lears AK, Ytterberg SR, Hummel AM, Viss MA, Peikert T, Stone JH, Specks U, WGET Research Group. Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis. Ann Intern Med. 2007 Nov 6; 147(9):611-9.
    View PubMed
  40. Finkielman JD, Lee AS, Hummel AM, Viss MA, Jacob GL, Homburger HA, Peikert T, Hoffman GS, Merkel PA, Spiera R, St Clair EW, Davis JC Jr, McCune WJ, Tibbs AK, Ytterberg SR, Stone JH, Specks U, WGET Research Group. ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis. Am J Med. 2007 Jul; 120(7):643.e9-14.
    View PubMed
  41. Seo P, Luqmani RA, Flossmann O, Hellmich B, Herlyn K, Hoffman GS, Jayne D, Kallenberg CG, Langford CA, Mahr A, Matteson EL, Mukhtyar CB, Neogi T, Rutgers A, Specks U, Stone JH, Ytterberg SR, Merkel PA. The future of damage assessment in vasculitis. J Rheumatol. 2007 Jun; 34(6):1357-71.
    View PubMed
  42. Baechler EC, Bauer JW, Slattery CA, Ortmann WA, Espe KJ, Novitzke J, Ytterberg SR, Gregersen PK, Behrens TW, Reed AM. An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity. Mol Med. 2007 Jan-Feb; 13(1-2):59-68.
    View PubMed
  43. Orzechowski NM, Ytterberg SR. 37-year-old woman with headache. Mayo Clin Proc. 2006 Oct; 81(10):1393-6.
    View PubMed
  44. Ytterberg SR. Treatment of refractory polymyositis and dermatomyositis. Curr Rheumatol Rep. 2006 Jun; 8(3):167-73.
    View PubMed
  45. Stone JH, Holbrook JT, Marriott MA, Tibbs AK, Sejismundo LP, Min YI, Specks U, Merkel PA, Spiera R, Davis JC, St Clair EW, McCune WJ, Ytterberg SR, Allen NB, Hoffman GS, Wegener's Granulomatosis Etanercept Trial Research Group. Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial. Arthritis Rheum. 2006 May; 54(5):1608-18.
    View PubMed
  46. Keogh KA, Ytterberg SR, Fervenza FC, Carlson KA, Schroeder DR, Specks U. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med. 2006 Jan 15; 173(2):180-7. Epub 2005 Oct 13.
    View PubMed
  47. Davis JM 3rd, Moder KG, Homburger HA, Ytterberg SR. Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: evidence for autoimmunity including neurologic and connective tissue diseases. Medicine (Baltimore) 2005 Jul; 84(4):208-17.
    View PubMed
  48. Seo P, Min YI, Holbrook JT, Hoffman GS, Merkel PA, Spiera R, Davis JC, Ytterberg SR, St Clair EW, McCune WJ, Specks U, Allen NB, Luqmani RA, Stone JH. Damage caused by Wegener's granulomatosis and its treatment - Prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET). Arthritis Rheum. 2005 Jul; 52(7):2168-78.
    View PubMed
  49. The Wegener’s Granulomatosis Etanercept Trial Research Group. Etanercept plus standard therapy for Wegener’s granulomatosis. N Engl J Med. 2005; 352(4):351-61.
  50. Wung PK, Holbrook JT, Hoffman GS, Tibbs AK, Specks U, Min Y-I, Merkel PA, Spiera R, Davis JC, St. Clair EW, McCune J, Ytterberg SR, Allen NB, Stone JH, for the WGET Research Group. Herpes zoster in immunocompromised patients: Incidence, timing, and risk factors. Am J Med. 2005; 118(12):1416.e9-18.
    View PubMed
  51. Leung N, Ytterberg SR, Blute ML, Lager DJ, Specks U, Fervenza FC. Wegener's granulomatosis presenting as multiple bilateral renal masses. Nephrol Dial Transplant. 2004 Apr; 19(4):984-7.
    View PubMed
  52. Stone JH, The WGET Research Group. Limited versus severe Wegener’s granulomatosis: Baseline data on patients in the Wegener’s granulomatosis etanercept trial. Arthritis Rheum. 2003; 48(8):2299-309.
  53. Rider LG, Giannini EH, Harris-Love M, Joe G, Isenberg D, Pilkington C, Lachenbruch PA, Miller FW, International Myositis Assessment Clinical Studies Group. Defining clinical improvement in adult and juvenile myositis. J Rheumatol. 2003; 30(3):603-17.
  54. Reed AM, Ytterberg SR. Genetic and environmental risk factors for idiopathic inflammatory myopathies. Rheum Dis Clin North Am. 2002 Nov; 28(4):891-916.
    View PubMed
  55. WGET Research Group. Design of the Wegener's Granulomatosis Etanercept Trial (WGET). Control Clin Trials. 2002 Aug; 23(4):450-68.
    View PubMed
  56. Cranmer LD, Warrington KJ, Ytterberg SR. 61-year-old man with dyspnea and bilateral foot drop. Mayo Clin Proc. 2002 Apr; 77(4):363-6.
    View PubMed
  57. Miller FW, Rider LG, Chung YL, Cooper R, Danko K, Farewell V, Lundberg I, Morrison C, Oakley L, Oakley I, Pilkington C, Vencovsky J, Vincent K, Scott DL, Isenberg DA, International Myositis Outcome Assessment Collaborative Study Group. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford). 2001 Nov; 40(11):1262-73.
    View PubMed
  58. Ytterberg SR. Polymyalgia rheumatica: Clinical features and management. Primary Care Case Reviews. 2001; 4(2):89-95.
    View PubMed
  59. Ytterberg SR. Viral arthritis. Curr Opin Rheumatol. 1999 Jul; 11(4):275-80.
    View PubMed
  60. Johnson JR, Burke MS, Mahowald ML, Ytterberg SR. Life-threatening reaction to vancomycin given for noninfectious fever. Ann Pharmacotherapy. 1999; 33(10):1043-5.
  61. Ytterberg SR, Harris IB, Allen SS, Anderson DC, Kofron PM, Kvasnicka JH, McCord JP, Moller JH. Clinical confidence and skills of medical students: use of an OSCE to enhance confidence in clinical skills. Acad Med. 1998 Oct; 73(10 Suppl):S103-5.
    View PubMed
  62. Ytterberg SR, Mahowald ML, Woods SR. Codeine and oxycodone use in patients with chronic rheumatic disease pain. Arthritis Rheum. 1998 Sep; 41(9):1603-12.
    View PubMed
  63. Stern EB, Callinan N, Hank M, Lewis EJ, Schousboe JT, Ytterberg SR. Neoprene splinting: dermatological issues. Am J Occup Ther. 1998 Jul-Aug; 52(7):573-8.
    View PubMed
  64. Ytterberg SR, Plotnikoff GA, Harris IB. Teaching professionalism through tutorial discussions of literature--stories, poems, and essays. Acad Med. 1998 May; 73(5):575-6.
    View PubMed
  65. Stern EB, Ytterberg SR, Krug HE, Larson LM, Portoghese CP, Kratz WN, Mahowald ML. Commercial wrist extensor orthoses: a descriptive study of use and preference in patients with rheumatoid arthritis. Arthritis Care & Research. 1997 Feb; 10(1):27-35.
    View PubMed
  66. Krug HE, Wietgrefe MM, Ytterberg SR, Taurog JD, Mahowald ML. Murine progressive ankylosis is not immunologically mediated. J Rheumatol. 1997 Jan; 24(1):115-22.
    View PubMed
  67. Allen S, Harris I, Ytterberg S, Anderson D, Kofron P, Kvasnicka J, Moller JH. Tailored response test: a new approach for teaching in medical education. Med Teach. 1997; 19(3):194-199.
  68. Ytterberg SR. Infectious agents associated with myopathies. Curr Opin Rheumatol. 1996 Nov; 8(6):507-13.
    View PubMed
  69. Stern EB, Ytterberg SR, Krug HE, Mahowald ML. Finger dexterity and hand function: effect of three commercial wrist extensor orthoses on patients with rheumatoid arthritis. Arthritis Care & Research. 1996 Jun; 9(3):197-205.
    View PubMed
  70. Harris IB, Kvasnicka JH, Ytterberg SR. Faculty development for community primary care preceptors. Acad Med. 1996 May; 71(5):567-8.
    View PubMed
  71. Stern EB, Ytterberg SR, Krug HE, Mullin GT, Mahowald ML. Immediate and short-term effects of three commercial wrist extensor orthoses on grip strength and function in patients with rheumatoid arthritis. Arthritis Care & Research. 1996 Feb; 9(1):42-50.
    View PubMed
  72. Pachman LM, Litt DL, Rowley AH, Hayford JR, Caliendo J, Heller S, Ticho BS, Christensen M, Patterson B, Ytterberg SR. Lack of detection of enteroviral RNA or bacterial DNA in magnetic resonance imaging-directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis. Arthritis Rheum. 1995 Oct; 38(10):1513-8.
    View PubMed
  73. Harris IB, Kvasnicka JH, Ytterberg SR. Faculty development for community primary care preceptors. Acad Med. 1995 May; 70(5):458-9.
    View PubMed
  74. Kvasnicka JH, Harris IB, Ytterberg SR. A program to provide early exposure to primary care role models: multiple benefits. Acad Med. 1995 May; 70(5):448-9.
    View PubMed
  75. Kvasnicka JH, Harris IB, Ytterberg SR. Using a student advisory group for curriculum assessment. Acad Med. 1995 May; 70(5):430-1.
    View PubMed
  76. Ytterberg SR. The relationship of infectious agents to inflammatory myositis. Rheum Dis Clin North Am. 1994 Nov; 20(4):995-1015.
    View PubMed
  77. Ytterberg SR, Watson K, Kvasnicka JH. Teaching and evaluating awareness of cultural and ethnic diversity in the medical encounter. Acad Med. 1994 May; 69(5):411-2.
    View PubMed
  78. Tam PE, Schmidt AM, Ytterberg SR, Messner RP. Duration of virus persistence and its relationship to inflammation in the chronic phase of coxsackievirus B1-induced murine polymyositis. Journal of Laboratory & Clinical Medicine. 1994 Mar; 123(3):346-56.
    View PubMed
  79. Ytterberg SR, Mahowald ML, Krug HE. Exercise for arthritis. Baillieres Clin Rheumatol. 1994 Feb; 8(1):161-89.
    View PubMed
  80. Ytterberg SR, Harris IB, Satran L, Allen SS, Anderson DC, Kofron PM, Moller JH, Whitley K, Miller WJ. Use of interactive computer technology with an innovative testing format - the tailored response test. Med Teach. 1994; 16(4):323-332.
  81. Ytterberg SR, Roelofs RI, Mahowald ML. Inclusion body myositis and renal cell carcinoma. Report of two cases and review of the literature. Arthritis Rheum. 1993 Mar; 36(3):416-21.
    View PubMed
  82. Ytterberg SR. Animal models of myopathy. Curr Opin Rheumatol. 1991 Dec; 3(6):934-40.
    View PubMed
  83. Tam PE, Schmidt AM, Ytterberg SR, Messner RP. Viral persistence during the developmental phase of Coxsackievirus B1-induced murine polymyositis. J Virol. 1991 Dec; 65(12):6654-60.
    View PubMed
  84. Ytterberg SR, Mahowald ML. Bacterial arthritis and osteitis in adults. Curr Opin Rheumatol. 1990 Aug; 2(4):606-15.
    View PubMed
  85. Mahowald ML, Krug H, Steveken ME, Ytterberg SR. Physical therapy for rheumatoid arthritis. J Musculoskeletal Med. 1990; 7(6):52-68.
  86. Mahowald MW, Mahowald ML, Bundlie SR, Ytterberg SR. Sleep fragmentation in rheumatoid arthritis. Arthritis Rheum. 1989 Aug; 32(8):974-83.
    View PubMed
  87. Ytterberg SR. Cellular immunity in polymyositis/dermatomyositis. Mt Sinai J Med. 1988 Nov; 55(6):494-500.
    View PubMed
  88. Mahowald ML, Steveken ME, Young M, Ytterberg SR. The Minnesota Arthritis Training Program: emphasis on self-management, not compliance. Patient Education & Counseling. 1988 Jun; 11(3):235-41.
    View PubMed
  89. Ytterberg SR, Mahowald ML, Messner RP. T cells are required for coxsackievirus B1 induced murine polymyositis. J Rheumatol. 1988 Mar; 15(3):475-8.
    View PubMed
  90. Ytterberg SR, Knodell RG, Mahowald ML. Use of the aminopyrine breath test to monitor hepatotoxicity caused by methotrexate in the treatment of rheumatoid arthritis. Contemp Orthop. 1988; 16(5):59-65.
  91. Mahowald ML, Ytterberg SR. A model for diagnostic decision making: a systemic approach to the patient with "joint pain". Cyberlog. 1988; 2(4):3-9.
  92. Mahowald ML, Krug HE, Ytterberg SR. Integration of the musculoskeletal examination into diagnostic decision-making. Cyberlog. 1988; 2(4):11-22.
  93. Mahowald ML, Ytterberg SR. Laboratory tests to aid in the diagnosis of joint pain. Cyberlog. 1988; 2(4):25-27.
  94. Ytterberg SR, Mahowald ML. Management strategies for inflammatory arthritis. Cyberlog. 1988; 2(4):29-45.
  95. Ytterberg SR, Knodell RG, Mahowald ML. Lack of methotrexate hepatotoxicity in rheumatoid arthritis. Contemp Gastroenterol. 1988; 1(1):21-26.
  96. Ytterberg SR, Mahowald ML, Messner RP. Coxsackievirus B 1-induced polymyositis. Lack of disease expression in nu/nu mice. J Clin Invest. 1987 Aug; 80(2):499-506.
    View PubMed
  97. Ytterberg SR. Coxsackievirus B 1 induced murine polymyositis: acute infection with active virus is required for myositis. J Rheumatol. 1987 Feb; 14(1):12-8.
    View PubMed
  98. Mahowald ML, Steveken ME, Ytterberg SR. Arthritis training program. Patient Education Newsletter (Mpls VAMC). 1987; 1(3):1-2.
  99. Ytterberg SR, Schnitzer TJ. Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus: roles of disease activity and serum interferon. Ann Rheum Dis. 1984 Jun; 43(3):457-61.
    View PubMed
  100. Ytterberg SR, Huard TK, Schnitzer TJ. Effects of serum from patients with system lupus erythematosus on leukocyte cytotoxicity: modulation of NK activity and ADCC. J Rheumatol. 1983 Dec; 10(6):906-12.
    View PubMed
  101. Ytterberg SR, Schnitzer TJ. Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum. 1982 Apr; 25(4):401-6.
    View PubMed